ReviewJournal of eating disorders2026
Clinical profiles of ARFID compared with anorexia and bulimia in young people: a systematic review and meta-analysis.
Review in Journal of eating disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pica, avoidant restrictive food intake disorder and rumination disorder in children and adolescents with autism spectrum disorder: A systematic review.Journal of eating disorders · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAvoidant/restrictive food intake disorder (ARFID) is a relatively recent diagnostic category within feeding and eating disorders and is increasingly recognized in pediatric populations. Although ARFID shares some clinical features with other eating disorders such as anorexia nervosa (AN) and bulimia nervosa (BN), important differences in psychiatric comorbidity, sex distribution, and clinical severity have been suggested.
objectiveThis systematic review and meta-analysis aimed to compare the clinical profiles of ARFID with those of AN and BN in children and adolescents, focusing on anxiety, depression, sex distribution, age, and hospitalization rates.
methodsA systematic search was conducted in PubMed, Embase, PsycINFO, Scopus, and Web of Science from database inception to November 2025. Observational studies including participants aged ≤ 18 years diagnosed with ARFID, AN, or BN and reporting comparative data for at least one outcome of interest were eligible. Random-effects meta-analyses were conducted to estimate pooled odds ratios (ORs) for each outcome.
resultsTwenty-two studies met the inclusion criteria. Compared with anorexia nervosa (AN), individuals with avoidant/restrictive food intake disorder (ARFID) showed significantly higher odds of anxiety (OR = 1.41, 95% CI: 1.05-1.89) and significantly lower odds of depressive disorders (OR = 0.30, 95% CI: 0.17-0.51). ARFID was also associated with a markedly higher proportion of males (OR = 4.18, 95% CI: 3.44-5.08) and lower hospitalization rates (OR = 0.23, 95% CI: 0.11-0.52). In addition, individuals with ARFID were significantly younger than those with AN (g = -0.90, 95% CI: -1.27 to -0.54). Comparisons with bulimia nervosa (BN) showed a similar pattern. Depressive disorders were significantly less frequent in ARFID (OR = 0.25, 95% CI: 0.12-0.53), and ARFID included a substantially higher proportion of males (OR = 5.29, 95% CI: 2.90-9.67). Anxiety tended to be higher in ARFID than in BN, although this difference did not reach statistical significance. Individuals with ARFID were also significantly younger than those with BN (g = -1.31, 95% CI: -1.89 to -0.74).
conclusionsARFID demonstrates a distinct clinical profile compared with AN and BN in children and adolescents, characterized by higher anxiety-related features, lower prevalence of depressive symptoms, a more balanced sex distribution, and lower hospitalization rates. These findings support ARFID as a distinct eating disorder in youth and underscore the need for tailored assessment and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.